Skip to content
OpenCapital
Get started

Wave Life Sciences WVE Accrued Progress Collections and Price Adjustments

Accrued Progress Collections and Price Adjustments at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
——
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
——

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's accrued progress collections and price adjustments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's accrued progress collections and price adjustments?
Wave Life Sciences (WVE) reported accrued progress collections and price adjustments of $14.6M in Q1 2026.
How has Wave Life Sciences's accrued progress collections and price adjustments changed year-over-year?
Wave Life Sciences's accrued progress collections and price adjustments increased by 161.4% year-over-year, from $5.58M to $14.6M.
What is the long-term trend for Wave Life Sciences's accrued progress collections and price adjustments?
Over 5 years (2020 to 2025), Wave Life Sciences's accrued progress collections and price adjustments has grown at a -28.4% compound annual growth rate (CAGR), from $41.48M to $7.8M.